Rob Dillard

DocwireNews

Less pediatric cancer patients are enrolling in clinical trials, according to the findings of a new study published in the journal PLoS ONE.&ldquo;<a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/whats-the-life-expectancy-for-childhood-cancer-survivors/">Childhood cancer</a> is rare overall,&rdquo; says the study&rsquo;s first author, Kelly Faulk, MD, CU Cancer Center investigator and pediatric oncologist at Children&rsquo;s Hospital Colorado, &ldquo;so historically high enrollment rates to clinical trials has been integral to improving outcomes for our patients.&rdquo;Researchers used Surveillance, Epidemiology, and End Results (SEER) database to estimate the overall number of pediatric cancer cases from 2004-2015, and then compared overall cancer numbers to the number of patients enrolled in clinical trials with the Children&rsquo;s Oncology Group (COG), the largest pediatric oncology cooperative group.According to the results, pediatric enrollment is down from 40-70% seen in studies completed in the 1990s, to 20-25% in the early 2000s, to 19.9% in the current study.&nbsp; The researchers found no significant racial, ethnic, or socioeconomic disparities within pediatric trial enrollment.&ldquo;They can feel lost between pediatric and adult cancer care, and unfortunately these AYA patients represent a population that has failed to see the same improvements in outcomes that their younger counterparts have,&rdquo; says Kelly Faulk, MD, CU Cancer Center investigator and pediatric oncologist at Children&rsquo;s Hospital Colorado in a <a href="https://www.eurekalert.org/pub_releases/2020-04/uoca-ssf042320.php">press release</a>. &ldquo;Given their age and other socioeconomic factors, they may not see doctors as often and commonly suffer from suboptimal health insurance coverage.&rdquo;<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
Study shows fewer kids enrolling in cancer clinical trials &ndash; EurekAlert <a href="https://t.co/G413MFOuvH">https://t.co/G413MFOuvH</a>
&mdash; Cancer Review (@CancerReview) <a href="https://twitter.com/CancerReview/status/1253394468545298433?ref_src=twsrc%5Etfw">April 23, 2020</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>&nbsp;&ldquo;We feel this study is a useful evaluation of pediatric and AYA trial enrollment, representing important shifts in the way we design and test new treatments, and highlighting areas where we can continue to improve our use of clinical trials to give our patients the best possible options,&rdquo; Faulk says.https://twitter.com/brightsurf/status/1253399756560191490&nbsp;&nbsp;&nbsp;

Sara Nunnery, MD, MSCI

Reclassifying HER2: What Oncologists Need to Know About HER2-Low and -Ultralow Breast Cancer

HER2 Breast Cancer

Jeffrey Perl, MD

Joel M. Topf, MD, FACP

Thoughts From the 2025 Lazarus Award Winner

NKF Spring Clinical Meetings 2025

Brandon Twyford

DESTINY-Breast09 Demonstrates First-Line Superiority of Enhertu Plus Pertuzumab in HER2-Positive Metastatic Breast Cancer

Latest News

Less Pediatric Cancer Patients Enrolling in Clinical, Study Shows

Oncology

Less pediatric cancer patients are enrolling in clinical trials, according to the findings of a new study published in the journal PLoS ONE. ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe